Amazon RxPass
A flat monthly subscription covering an unlimited supply of a fixed list of common generic medications, for Amazon Prime members.
Best for
Prime members who take two or more common generics every month and are paying cash for them.
Why Kave includes this
The price is one published number regardless of how many of the covered drugs you take, which makes it trivially comparable against a copay — the arithmetic most drug pricing hides. Kave lists it with the two constraints stated up front: it requires a paid Prime membership, and people on Medicare or Medicaid are excluded.
- Expected cost
- A flat monthly fee on top of an Amazon Prime membership, covering an unlimited supply of the eligible generics list. The eligible list is published.
- Insurance requirement
- Does not use insurance. Not available to people enrolled in Medicare, Medicaid, or other government-funded prescription coverage.
- Who qualifies
- Requires an Amazon Prime membership and a prescription for a drug on the eligible list, in a state where the service operates.
- Where it is available
- Nationwide (United States)
- How you use it
- Online or by phone
- Languages
- English
Limitations Kave wants you to know about
- Excludes anyone on Medicare, Medicaid, or another government drug benefit.
- Only covers drugs on the published eligible list — check yours before subscribing.
- Requires a paid Prime membership, which is a real cost on top of the monthly fee.
- Mail order, so not suitable for a medication you need today.
Verification
Compiled by Kave on July 1, 2026 and link-checked. Not yet independently verified. Kave assembled this from the organisation’s own published material and confirmed the links resolve. No reviewer has confirmed the eligibility details against the source, so check them on the official site before you rely on them.
- Compiled
- July 1, 2026 (28 days ago)
- Next scheduled review
- September 29, 2026
- Reviewed by
- Not yet reviewed
Sources used
- Amazon Pharmacy — RxPass — read July 1, 2026
Kave quality score
77/100
Kave lists resources scoring 80 or above that also clear all four mandatory gates.
- Patient impact17.5/25
- Affordability or financial value16.4/20
- Transparency13.8/15
- Accessibility9.3/15
- Ease of use8.8/10
- Geographic reach4.4/5
- Institutional credibility3.5/5
- Privacy and data practices2.9/5
Geographic reach is deliberately worth only five points, so a strong local resource is not pushed out by a weak national one. Read the methodology.